These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28687604)

  • 41. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.
    Toonen LJ; Schmidt I; Luijsterburg MS; van Attikum H; van Roon-Mom WM
    Sci Rep; 2016 Oct; 6():35200. PubMed ID: 27731380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.
    Durcan TM; Kontogiannea M; Thorarinsdottir T; Fallon L; Williams AJ; Djarmati A; Fantaneanu T; Paulson HL; Fon EA
    Hum Mol Genet; 2011 Jan; 20(1):141-54. PubMed ID: 20940148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
    Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L
    Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia.
    Nóbrega C; Mendonça L; Marcelo A; Lamazière A; Tomé S; Despres G; Matos CA; Mechmet F; Langui D; den Dunnen W; de Almeida LP; Cartier N; Alves S
    Acta Neuropathol; 2019 Nov; 138(5):837-858. PubMed ID: 31197505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease models.
    Marcelo A; Brito F; Carmo-Silva S; Matos CA; Alves-Cruzeiro J; Vasconcelos-Ferreira A; Koppenol R; Mendonça L; de Almeida LP; Nóbrega C
    Hum Mol Genet; 2019 Jan; 28(1):51-63. PubMed ID: 30219871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3.
    Haacke A; Hartl FU; Breuer P
    J Biol Chem; 2007 Jun; 282(26):18851-6. PubMed ID: 17488727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Far-infrared Radiation Improves Motor Dysfunction and Neuropathology in Spinocerebellar Ataxia Type 3 Mice.
    Liu SW; Chang JC; Chuang SF; Liu KH; Cheng WL; Chang HJ; Chang HS; Lin TT; Hsieh CL; Lin WY; Hsieh M; Kuo SJ; Liu CS
    Cerebellum; 2019 Feb; 18(1):22-32. PubMed ID: 29725949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trehalose alleviates the phenotype of Machado-Joseph disease mouse models.
    Santana MM; Paixão S; Cunha-Santos J; Silva TP; Trevino-Garcia A; Gaspar LS; Nóbrega C; Nobre RJ; Cavadas C; Greif H; Pereira de Almeida L
    J Transl Med; 2020 Apr; 18(1):161. PubMed ID: 32272938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
    Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
    Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Planning Future Clinical Trials for Machado-Joseph Disease.
    Saute JAM; Jardim LB
    Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trehalose prevents the formation of aggregates of mutant ataxin-3 and reduces soluble ataxin-3 protein levels in an SCA3 cell model.
    Wang Z; Wang M; Huang Y; Ma Z; Gao W; Zhang T; Deng J; Cheng X; Liu Y; Wang B; Qi Y; Yang M; He F
    Neuroscience; 2024 Sep; 555():76-82. PubMed ID: 38964453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.
    Oliveira Miranda C; Marcelo A; Silva TP; Barata J; Vasconcelos-Ferreira A; Pereira D; Nóbrega C; Duarte S; Barros I; Alves J; Sereno J; Petrella LI; Castelhano J; Paiva VH; Rodrigues-Santos P; Alves V; Nunes-Correia I; Nobre RJ; Gomes C; Castelo-Branco M; Pereira de Almeida L
    Mol Ther; 2018 Sep; 26(9):2131-2151. PubMed ID: 30087083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Koeppen AH
    Adv Exp Med Biol; 2018; 1049():233-241. PubMed ID: 29427106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.
    Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L
    Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spastic paraparesis as the first manifestation of Machado-Joseph disease: A case report and review of the literature.
    Lin HC; Chang YY; Chang KH; Chen YF; Lan MY
    Clin Neurol Neurosurg; 2018 Sep; 172():137-140. PubMed ID: 30007589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
    Tsai HF; Tsai HJ; Hsieh M
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias.
    Colomer Gould VF
    NeuroRx; 2005 Jul; 2(3):480-3. PubMed ID: 16389311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.
    Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M
    J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.
    Potapenko A; Davidson JM; Lee A; Laird AS
    Biochem J; 2024 Mar; 481(6):461-480. PubMed ID: 38497605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.